Back to Results
First PageMeta Content
DNA / DNA methylation / Epigenetics / Myelodysplastic syndrome / Hypomethylating agent / Decitabine / Biology / Medicine / Nucleosides / Triazines


ABST # A190 In Vivo Activity of SGI-110, a Novel Hypomethylating Agent for Treatment in Hematology and Solid Malignancies Jason Scholl, David Vollmer, Jared Bearss, Carissa Jones, Virgil McCarthy, Paul Severson, Sanjeev
Add to Reading List

Document Date: 2012-12-13 18:06:00

Open Document

File Size: 458,85 KB

Share Result on Facebook

City

Dublin / /

Company

David Bearss SuperGen Inc. / CBC / /

Event

FDA Phase / /

MedicalCondition

tumor / solid tumor / solid tumors / myelodysplastic syndrome / /

Organization

FDA / /

Person

Jared Bearss / Carissa Jones / Sanjeev Redkar / Paul Severson / Virgil McCarthy / Roger Inloes / /

Product

SGI-110 / /

Technology

drug delivery / /

SocialTag